RxSight (RXST) EPS (Basic) Growth (1y) (2021 - 2026)
RxSight (RXST) EPS (Basic) Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.61 Bn | 194.01 Bn | 7.27 Bn | -47.75% |
| 2 | Stryker | 127.81 Bn | 124.34 Bn | 4.50 Bn | 43.85% |
| 3 | Medtronic | 119.04 Bn | 109.82 Bn | 6.41 Bn | 18.90% |
| 4 | Boston Scientific | 73.68 Bn | 73.14 Bn | 3.85 Bn | 14.55% |
| 5 | Edwards Lifesciences | 51.96 Bn | 47.71 Bn | 1.35 Bn | -25.84% |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn | 42.13% |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | 15.81% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 72.17% |
| 9 | Steris | 23.06 Bn | 22.58 Bn | 684.20 Mn | 13.85% |
| 10 | RxSight | 249.98 Mn | -154.26 Mn | - | -0.79% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.79% |
| Mar 31, 2026 | -90.20% |
| Dec 31, 2025 | -48.95% |
| Sep 30, 2025 | -50.43% |
| Jun 30, 2025 | -82.99% |
| Mar 31, 2025 | 18.15% |
| Dec 31, 2024 | -110.44% |
| Sep 30, 2024 | 54.24% |
| Jun 30, 2024 | 60.49% |
| Mar 31, 2024 | 40.86% |
| Dec 31, 2023 | -25.52% |
| Sep 30, 2023 | 42.73% |
| Jun 30, 2023 | 34.09% |
| Mar 31, 2023 | 34.91% |
| Dec 31, 2022 | 267.50% |
| Sep 30, 2022 | 10.14% |
| Jun 30, 2022 | 81.50% |
| Mar 31, 2022 | 62.32% |
| Dec 31, 2021 | -226.62% |
| Jun 30, 2021 | 29.53% |